Market Cap (In IDR)
255.36 Billion
Revenue (In IDR)
1014.12 Billion
Net Income (In IDR)
5.95 Billion
Avg. Volume
202.21 Thousand
- Currency
- IDR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 280.0-865.0
- PE
- -
- EPS
- -
- Beta Value
- 0.287
- ISIN
- ID1000147507
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Ida Rahmi Kurniasih
- Employee Count
- -
- Website
- https://www.phapros.co.id
- Ipo Date
- 2018-12-26
- Details
- PT Phapros, Tbk operates in the pharmaceutical and health care industry in Indonesia. The company operates through Over the Counter (OTC), Ethical, Generic Drugs Bearing, and Toll Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others. The company also provides generic drug products for government institutions and hospitals, as well as produces drugs for other pharmaceutical industries; and offers medical devices. PT Phapros, Tbk also exports its products internationally. The company was founded in 1954 and is headquartered in Jakarta, Indonesia. PT Phapros, Tbk operates as a subsidiary of PT Kimia Farma (Persero) Tbk.
More Stocks
-
MLFNFMaple Leaf Foods Inc.
MLFNF
-
5487
-
GFCOFThe Good Flour Corp.
GFCOF
-
8024
-
3447
-
000859
-
0125
-
UGROCAPUGRO Capital Limited
UGROCAP